Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 7c; Boosts FY16 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks gain, oil prices slide
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Zimmer Biomet (ZBH) PT Raised to $134 at Needham & Company
April 28, 2016 1:46 PM EDTNeedham & Company analyst Mike Matson reiterated a Buy rating and boosted his price target on Zimmer Biomet (NYSE: ZBH) to $134.00 (from $129.00).
Matson commented, "ZBH beat consensus revenue and EPS in 1Q16 and management raised guidance. Pro forma constant currency revenue growth improved to... More
